Glipizide

CAS 29094-61-9 21 FDA-DMF suppliersSmall Molecule

Overview

Glipizide is a second-generation sulfonylurea used to control blood sugar levels in patients with type 2 diabetes. It functions by stimulating the release of insulin from the beta cells of the pancreas.

API suppliers (25)

Suppliers of Glipizide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • AMSA SPA1 active DMF
  • USV PRIVATE LTD1 active DMF
  • FERMION OYFinland1 active DMF
  • AMSA SPA1 active DMF
  • PHARMACIA AND UPJOHN CO WHOLLY OWNED SUB PFIZER INC1 active DMF
  • FERMION OYFinland1 active DMF
  • URQUIMA SA1 active DMF
  • USV PRIVATE LTD1 active DMF
  • AMSA SPA1 active DMF
  • SRI KRISHNA PHARMACEUTICALS LTDIndia1 active DMF
  • TAIZHOU HISOUND PHARMACEUTICAL CO LTDChina1 active DMF
  • CAMBREX PROFARMACO MILANO SRLItaly1 active DMF
  • OLON SPAItaly1 active DMF
  • URQUIMA SA1 active DMF
  • TAIZHOU HISOUND PHARMACEUTICAL CO LTDChina1 active DMF
  • FERMION OYFinland1 active DMF
  • FERMION OYFinland1 active DMF
  • AMSA SPA1 active DMF
  • TAIZHOU HISOUND PHARMACEUTICAL CO LTDChina1 active DMF
  • SUMITOMO CHEMICAL CO LTDJapan
  • PROSTINEX
  • Abbott LaboratoriesUSA
  • CHINA CHEMICAL SYNTHESIS INDUSTRIAL CO LTD
  • Lupin LimitedIndia
  • FINE CHEMICALS CORP PTY LTD

Therapeutic areas

EndocrinologyDiabetes Care

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.